{"id":825374,"date":"2025-03-13T08:10:42","date_gmt":"2025-03-13T12:10:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/"},"modified":"2025-03-13T08:10:42","modified_gmt":"2025-03-13T12:10:42","slug":"precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/","title":{"rendered":"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">GERMANTOWN, Md.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 13, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4378730-1&amp;h=184705996&amp;u=https%3A%2F%2Fprecigen.com%2F&amp;a=Precigen%2C+Inc.\" target=\"_blank\" rel=\"nofollow\">Precigen, Inc.<\/a>\u00a0(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will release full year 2024 financial results and provide business updates on <span class=\"xn-chron\">Wednesday, March 19, 2025<\/span>. The Company will host a conference call to discuss results that day at <span class=\"xn-chron\">4:30 PM ET<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg\" title=\"Precigen Logo (PRNewsfoto\/Precigen, Inc.)\" alt=\"Precigen Logo (PRNewsfoto\/Precigen, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The conference call may be accessed by dialing 1-800-836-8184 (<span class=\"xn-location\">North America<\/span>) or 1-646-357-8785 (International). Participants are asked to dial in 10-15 minutes in advance of the scheduled call time to facilitate timely connection to the call.<\/p>\n<p>Event details can be found on Precigen&#8217;s website in the Events &amp; Presentations section at <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4378730-1&amp;h=2399065666&amp;u=https%3A%2F%2Finvestors.precigen.com%2Fevents-presentations&amp;a=investors.precigen.com%2Fevents-presentations\" target=\"_blank\" rel=\"nofollow\">investors.precigen.com\/events-presentations<\/a>.<\/p>\n<p>\n        <b>Precigen: Advancing Medicine with Precision<\/b><br \/>\n        <b><br \/>\n          <sup>\u00ae<br \/><\/sup><br \/>\n        <\/b>Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated therapies toward clinical proof-of-concept and commercialization. For more information about Precigen, visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4378730-1&amp;h=1088143024&amp;u=http%3A%2F%2Fwww.precigen.com%2F&amp;a=www.precigen.com\" target=\"_blank\" rel=\"nofollow\">www.precigen.com<\/a>\u00a0or follow us on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4378730-1&amp;h=1823163379&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fprecigen%2F&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a> or <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4378730-1&amp;h=1993920444&amp;u=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCbd51C9ftUDEnSfbheMjF2Q&amp;a=YouTube\" target=\"_blank\" rel=\"nofollow\">YouTube<\/a>.<\/p>\n<p>\n        <b>Cautionary Statement Regarding Forward-Looking Statements<br \/><\/b>Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon the Company&#8217;s current expectations and projections about future events and generally relate to plans, objectives, and expectations for the development of the Company&#8217;s business, including the timing and progress of preclinical studies, clinical trials, discovery programs and related milestones, the promise of the Company&#8217;s portfolio of therapies, and in particular its CAR-T and AdenoVerse therapies. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. For further information on potential risks and uncertainties, and other important factors, any of which could cause the Company&#8217;s actual results to differ from those contained in the forward-looking statements, see the section entitled &#8220;Risk Factors&#8221; in the Company&#8217;s most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.<\/p>\n<p>\n        <b>Investor Contact:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Steven M. Harasym<\/span><br \/>\n        <br \/>Tel: +1 (301) 556-9850<br \/><a href=\"mailto:investors@precigen.com\" rel=\"nofollow\">investors@precigen.com<\/a><\/p>\n<p>\n        <b>Media Contacts:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Donelle M. Gregory<\/span><br \/>\n        <br \/>\n        <a href=\"mailto:press@precigen.com\" rel=\"nofollow\">press@precigen.com<\/a>\n      <\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY36424&amp;sd=2025-03-13\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th-302400648.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th-302400648.html<\/a><\/p>\n<p>SOURCE  Precigen, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY36424&amp;Transmission_Id=202503130805PR_NEWS_USPR_____NY36424&amp;DateId=20250313\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire GERMANTOWN, Md. , March 13, 2025 \/PRNewswire\/ &#8212;\u00a0Precigen, Inc.\u00a0(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will release full year 2024 financial results and provide business updates on Wednesday, March 19, 2025. The Company will host a conference call to discuss results that day at 4:30 PM ET. The conference call may be accessed by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (International). Participants are asked to dial in 10-15 minutes in advance of the scheduled call time to facilitate timely connection to the call. Event details can be found on Precigen&#8217;s website in the Events &amp; Presentations section at investors.precigen.com\/events-presentations. Precigen: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-825374","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire GERMANTOWN, Md. , March 13, 2025 \/PRNewswire\/ &#8212;\u00a0Precigen, Inc.\u00a0(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will release full year 2024 financial results and provide business updates on Wednesday, March 19, 2025. The Company will host a conference call to discuss results that day at 4:30 PM ET. The conference call may be accessed by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (International). Participants are asked to dial in 10-15 minutes in advance of the scheduled call time to facilitate timely connection to the call. Event details can be found on Precigen&#8217;s website in the Events &amp; Presentations section at investors.precigen.com\/events-presentations. Precigen: &hellip; Continue reading &quot;Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-13T12:10:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th\",\"datePublished\":\"2025-03-13T12:10:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/\"},\"wordCount\":480,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/694013\\\/Precigen_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/\",\"name\":\"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/694013\\\/Precigen_Logo.jpg\",\"datePublished\":\"2025-03-13T12:10:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/694013\\\/Precigen_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/694013\\\/Precigen_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/","og_locale":"en_US","og_type":"article","og_title":"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - Market Newsdesk","og_description":"PR Newswire GERMANTOWN, Md. , March 13, 2025 \/PRNewswire\/ &#8212;\u00a0Precigen, Inc.\u00a0(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will release full year 2024 financial results and provide business updates on Wednesday, March 19, 2025. The Company will host a conference call to discuss results that day at 4:30 PM ET. The conference call may be accessed by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (International). Participants are asked to dial in 10-15 minutes in advance of the scheduled call time to facilitate timely connection to the call. Event details can be found on Precigen&#8217;s website in the Events &amp; Presentations section at investors.precigen.com\/events-presentations. Precigen: &hellip; Continue reading \"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-13T12:10:42+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th","datePublished":"2025-03-13T12:10:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/"},"wordCount":480,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/","name":"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg","datePublished":"2025-03-13T12:10:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/694013\/Precigen_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precigen-to-announce-full-year-2024-financial-results-and-provide-business-updates-on-march-19th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=825374"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825374\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=825374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=825374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=825374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}